About the Authors
- Mario Nuvolone
-
* E-mail: mario.nuvolone@unipv.it (MN); adriano.aguzzi@usz.ch (AA)
Affiliations Institute of Neuropathology, University Hospital of Zurich, Zurich, Switzerland, Amyloidosis Research and Treatment Center, Foundation Scientific Institute Policlinico San Matteo, Department of Molecular Medicine, University of Pavia, Pavia, Italy
- Marta Paolucci
-
Affiliation Institute of Neuropathology, University Hospital of Zurich, Zurich, Switzerland
- Silvia Sorce
-
Affiliation Institute of Neuropathology, University Hospital of Zurich, Zurich, Switzerland
- Veronika Kana
-
Affiliation Institute of Neuropathology, University Hospital of Zurich, Zurich, Switzerland
- Rita Moos
-
Affiliation Institute of Neuropathology, University Hospital of Zurich, Zurich, Switzerland
- Takashi Matozaki
-
Affiliation Division of Molecular and Cellular Signaling, Department of Biochemistry and Molecular Biology, Kobe University Graduate School of Medicine, Kobe, Japan
- Adriano Aguzzi
-
* E-mail: mario.nuvolone@unipv.it (MN); adriano.aguzzi@usz.ch (AA)
Affiliation Institute of Neuropathology, University Hospital of Zurich, Zurich, Switzerland
Competing Interests
Adriano Aguzzi is a founder, director, and shareholder of Mabylon, a company dedicated to the discovery of human disease-related antibodies. He does not receive any salary from Mabylon who did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter our adherence to PLOS ONE policies on sharing data and materials.
Author Contributions
Conceptualization: MN VK AA. Data curation: MN MP. Formal analysis: MN MP AA. Funding acquisition: AA. Investigation: MN MP SS RM. Methodology: MN SS TM AA. Project administration: MN AA. Resources: TM AA. Supervision: AA. Validation: MN AA. Visualization: MN MP. Writing – original draft: MN MP AA. Writing – review & editing: SS VK RM TM.